Cardiology Services Subcutaneous S-ICD™ System A new option for patients at risk of sudden cardiac arrest Sudden cardiac arrest, when the heart suddenly and unexpectedly stops beating effectively, is one of the leading causes of death in the United States each year. The most common treatment for those at risk of SCA is an implantable cardioverter defibrillator, or ICD. This device is designed to administer lifesaving therapy in the event of a cardiac arrest. Although ICDs have been in use for decades, recent breakthroughs in technology offer patients new alternatives with fewer complications. What are the types of ICDs? subcutaneous Transvenous (Conventional) Images courtesy of Boston Scientific • Implanted under the skin on the left side • Implanted in the upper chest • Connected to an electrode implanted • Connected to wires with electrodes • Less invasive, leaves heart untouched and • Invasive, connected to heart of the chest, below the armpit under the skin along rib margin therefore results in fewer complications • Shocks the heart externally, cannot be used by patients who also need pacing inserted in the heart muscle through a vein in the upper chest chambers via transvenous leads • Shocks the heart internally, can perform long-term cardiac pacing What are the benefits of Boston Scientific’s Subcutaneous S-ICD™ System? The S‐ICD™ System is the world’s first and only ICD that provides defibrillation therapy without touching the heart. Like conventional ICDs, Boston Scientific’s S‐ICD™ System provides effective defibrillation for life‐threatening ventricular arrhythmias. However, the S‐ICD™ System leaves the heart and vasculature untouched. This FDA-approved system introduces a new category of defibrillators that offer patients a choice in their treatment. The S-ICD™ System is implanted just underneath the skin. There is nothing in or on the heart. What are the benefits of the S-ICD™ System? While there are some restrictions, the S-ICD™ System is an exciting therapeutic solution that can be used by most patients needing an implantable defibrillator. This option offers an added benefit for patients undergoing dialysis who are at risk for infection, as well as younger patients who wish to maintain an active lifestyle. The system offers defibrillation therapy only and is not for use in patients who are also in need of a pacemaker or cardiac resynchronizing therapy. Implantation of a subcutaneous ICD typically takes one hour, with the patient going home the same day in most cases. Most patients experience some pain or soreness following the procedure and find the placement of the device is much more comfortable than conventional ICDs. Subcutaneous ICD services at WSUPG meet our dedicated team Mazhar Khan, M.D., F.A.A.C., is a board-certified cardiologist who is also board-certified in clinical cardiac electrophysiology. He is director of arrhythmia services for WSUPG and specializes in heart rhythm disorders, as well as device-based therapies. Ismeta Muhovic, C.C.D.S., C.C.T., is a cardiac device specialist and certified cardiographic technician. She has an extensive background in quality and has been a member of the American Society for Quality since 1990. For more information call 313-745-4525 or visit upgdocs.org/cardiology. contact us Patient Appointments 313-745-4525 Physician Referrals 313-745-4525 Medication fax: 313-448-9199 General fax: 313-993-0085 Cardiac Device Clinic University Health Center 4C 4201 St. Antoine St. Detroit, MI 48201 Implantation Procedures Oakwood Hospital – Dearborn 18101 Oakwood Blvd. Dearborn, MI 48124 Rev. 7/14